Canaccord analyst Richard Close lowered the firm’s price target on Progyny (PGNY) to $17 from $18 and keeps a Hold rating on the shares. The firm lowered its estimates after another quarter falling short of expectations and lowering of guidance.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.